Glaxo drug discovery and development research grants.Glaxo Drug Discovery and Development Research Grants (Including Microbicides); Deadline July 31 GlaxoSmithKline will award research grants from $25,000 to $150,000 ($500,000 total) "for innovative HIV/AIDS HIV/AIDS Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome drug research in recognition of the need to produce new alternatives and hope in the fight against the HIV/AIDS pandemic pandemic /pan·dem·ic/ (pan-dem´ik) 1. a widespread epidemic of a disease. 2. widely epidemic. pan·dem·ic adj. Epidemic over a wide geographic area. n. ." These grants "are intended to further the development of inventive treatments for HIV/AIDS, including: therapies aimed at treating infection; prophylactic prophylactic /pro·phy·lac·tic/ (pro?-fi-lak´tik) 1. tending to ward off disease; pertaining to prophylaxis. 2. an agent that tends to ward off disease. pro·phy·lac·tic n. vaccines; or microbicides designed to prevent transmission of the virus." Applications will be judged by a panel of outside experts; recipients will be announced at the ICAAC ICAAC Interscience Conference on Antimicrobial Agents and Chemotherapy ICAAC Iowa Community College Athletic Conference conference in September 2003; and the grants will be paid by November 1. There is no obligation to license resulting technologies to Glaxo. For more information and application forms, visit http://www.dddresearchgrant.com or call 888-527-6935. |
|
||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion